Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis
Open Access
- 1 April 1999
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (4) , 807-811
Abstract
Autologous transplantation of hematopoietic stem cells has recently been proposed as a possible treatment for autoimmune diseases that are associated with a very severe prognosis. A 12‐year‐old girl who, since 4 years of age, had systemic sclerosis with progressive pulmonary involvement underwent autologous peripheral blood–derived stem cell transplantation (aPBSCT) using CD34+ selection, cyclophosphamide, and the infusion of the monoclonal antibody CAMPATH‐1G. Following transplantation, in the absence of any treatment other than symptomatic therapy, the patient's exertional dyspnea and alveolitis disappeared and she experienced a marked improvement in skin score, height velocity, and general well‐being that has persisted 2 years after the transplantation procedure. Autologous PBSCT associated with the infusion of the monoclonal antibody CAMPATH‐1G appears to be a useful therapy for otherwise intractable forms of progressive systemic sclerosis.Keywords
This publication has 13 references indexed in Scilit:
- Hematopoietic Stem-Cell Transplantation for Systemic Lupus ErythematosusNew England Journal of Medicine, 1997
- Autologous bone-marrow transplantation for rheumatoid arthritisThe Lancet, 1997
- Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin’s lymphomaBone Marrow Transplantation, 1997
- Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)Rheumatology, 1997
- Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpuraThe Lancet, 1997
- Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.Journal of Clinical Oncology, 1997
- Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantationThe Lancet, 1997
- Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease.Annals of the Rheumatic Diseases, 1996
- Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosisCurrent Opinion in Rheumatology, 1995
- Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three‐year, parallel, randomized, double‐blind studyArthritis & Rheumatism, 1989